入华十年，Swisse斯维诗想定义健康消费新范式 过去十年，堪称是中国新消费赛道高速发展的十年。作为其中的代表性领域，中国营养健康市场也经历 了从野蛮生长到监管趋于规范，消费者信任缺失到开始追求品质的变化。 大浪淘沙的阶段，入局者数不胜数，都渴望在这片潜力巨大的蓝海市场中抢占先机。如今回看产业的发 展历程，一个颇为有趣的现象是，在消费者心中建立起深度联结和信任的，似乎并不只是一些长期深耕 本土的传统品牌，还有不少年轻的"外来者"。 成长于澳洲的Swisse就是其中的一个。 这家有着"外来基因"的营养品品牌，在十年间一路突破了地域认知壁垒、消费习惯差异等多重挑战。据 健合集团相关信息，如今，斯维诗在国内维生素、草本及矿物补充剂（VHMS）的市场排名已位居第 一；此外，2025年前三季度，集团的成人营养与护理品（ANC）板块收入达到52.4亿元。其中，斯维诗 中国市场业绩同比增长15.7%，贡献了近七成的销售额。 12月8日，Swisse在广州开展了主题为"聚力共赢 稳健增长"的十周年合作伙伴大会。大会上，斯维诗表 示将继续通过"核心专业品类深化"与"新兴赛道拓展"双轮驱动，更全面、精准地满足消费者日益多元的 健 ...

过去十年，堪称是中国新消费赛道高速发展的十年。作为其中的代表性领域，中国营养健康市场也经历了从野蛮生长到监管趋于规范，消费者信任缺失到开 始追求品质的变化。 大浪淘沙的阶段，入局者数不胜数，都渴望在这片潜力巨大的蓝海市场中抢占先机。如今 回看产业 的 发展 历程，一个颇为有趣的现象是，在消费者心中 建立起深度联结和信任的，似乎并不只是一些长期深耕本土的传统品牌，还有不少年轻的 "外来者"。 成长于澳洲的Swisse就是其中的一个。 这家有着 "外来基因"的营养品品牌，在十年间一路突破了地域认知壁垒、消费习惯差异等多重挑战。据健合集团相关信息， 如今， 斯维诗 在 国内维生 素、草本及矿物补充剂（ VHMS） 的 市场 排名 已位居第一 ； 此外， 2025年前三季度，集团的成人营养与护理品（ANC）板块收入达到52.4亿元。 其 中，斯维诗中国市场业绩同比增长 15.7%，贡献了近七成的销售额。 12月8日，Swisse在广州开展了主题为"聚力共赢 稳健增长"的十周年合作伙伴大会。大会上，斯维诗表示将继续通过"核心专业品类深化"与"新兴赛道拓 展"双轮驱动，更全面、精准地满足消费者日益多元的健康需求，实现品牌 ...

Core Viewpoint - Amway has evolved over 30 years in China, transforming from a foreign entity into a significant local innovator, contributing to the health and wellness sector through localized research and development [1][2]. Group 1: Innovation and Research - Amway has established the largest plant variety resource library in the industry, with over 200 plant species and more than 900 varieties, including 304 varieties of lotus and 131 varieties of blueberries [5]. - The company collaborates with prestigious institutions like the Chinese Academy of Traditional Chinese Medicine and the Nanjing Institute of Soil Sciences, achieving breakthroughs in plant nutrition research [5]. - Amway's plant research center has successfully sequenced the entire genome of chrysanthemum, filling an international gap, and has been awarded for pioneering the application of plant DNA molecular identification technology [5][7]. Group 2: Localized Production and Supply Chain - Amway operates over 2,500 hectares of owned farms in the U.S., Mexico, and Brazil, and has 134 certified organic farms globally, focusing on sustainable plant cultivation [8]. - The company plans to invest in its first organic farm in China, located in Sichuan, which will focus on the cultivation of traditional Chinese medicinal herbs [8]. - The Guangzhou production base supports 55% of Amway's global product sales and serves over 50 countries, becoming a crucial hub in Amway's global supply chain [15]. Group 3: Product Innovation and Market Strategy - Amway has transitioned from "follow-up localization" to "leading localization," launching several successful products based on traditional Chinese medicine that have gained international acclaim [14]. - The company has introduced several flagship products, such as Ginkgo Biloba and various health supplements, achieving significant sales milestones, including over 20 billion yuan in sales for "基源欣活" within two years [15]. - Amway's strategy has shifted towards providing comprehensive health solutions, integrating digital tools and community engagement to enhance customer experience and partner involvement [21][22]. Group 4: Future Investments and Growth - Amway announced a five-year investment plan of 2.1 billion yuan to enhance its operations in China, including 700 million yuan for upgrading the Guangzhou production base and 400 million yuan for digital infrastructure [24]. - The company aims to strengthen its research capabilities, including the establishment of its organic farm and advancements in plant anti-aging research [24]. - Amway's commitment to the Chinese market is reflected in its role as a "city partner" in Guangzhou, focusing on health promotion and community building [22].

Core Viewpoint - Amway (China) celebrates its 30th anniversary and the opening of the "Amway Beautiful Life Plaza" in Guangzhou, marking a significant milestone in its development in China [2][21]. Group 1: Innovation and Research - Amway has established the largest plant variety resource library in the industry, with over 200 types and 900 varieties of plants, including 304 varieties of lotus and 131 varieties of blueberries [5]. - The company collaborates with prestigious institutions like the Chinese Academy of Traditional Chinese Medicine and the Nanjing Institute of Soil Sciences, achieving breakthroughs in plant nutrition research [5]. - Amway's plant research center has completed the whole genome sequencing of chrysanthemum, filling an international gap, and has been awarded the "International Contribution Award for Traditional Chinese Medicine" for its pioneering work in plant DNA molecular identification technology [5]. Group 2: Sustainable Agriculture and Localized Production - Amway is investing in a new organic farm in Sichuan, China, which will focus on the cultivation of traditional Chinese medicinal herbs and aims to enhance the quality and safety of its product raw materials [6]. - The company operates over 2,500 hectares of its own farms in the U.S., Mexico, and Brazil, and has 134 certified organic farms globally, emphasizing organic and sustainable planting methods [6]. Group 3: Market Strategy and Product Development - Amway has transitioned from "follow-up localization" to "leading localization," establishing China as a key market and innovation engine, with localized product development and production [11]. - The company has launched several successful products based on traditional Chinese medicine, such as Ginkgo Biloba tablets, which have generated over $3 billion in sales globally [12]. - Amway's Guangzhou production base supports 55% of its global product sales and serves over 50 countries, becoming a crucial hub in its global supply chain [12][14]. Group 4: Investment and Future Plans - Amway announced a five-year investment plan of 2.1 billion RMB, which includes 700 million RMB for upgrading its Guangzhou production base and 400 million RMB for enhancing digital infrastructure [21]. - The investment also allocates 500 million RMB for research and development, including projects on organic farm construction and plant anti-aging research [21]. Group 5: Community Engagement and Social Responsibility - Amway is recognized as a "strategic partner" in Guangzhou's "City Partner" initiative, focusing on health promotion, ecological friendliness, and community building [19]. - The company aims to integrate its resources with community efforts to create a vibrant and warm urban environment, reflecting its commitment to social responsibility [19][23].

临近年底，又到了人们开始集中选购节日礼物的时间。送健康礼，已经随着人们保健意识的提升，成为深入人心 的理念。在健康礼市场，益生菌凭借广泛的适应人群等特点脱颖而出，市场规模突破千亿级别。 如何成功掘金千亿益生菌市场，菌株研发、包埋技术等成为多家企业竞争和技术创新的核心点。其中，江中益生 菌凭借自主循证菌株和公司在胃肠健康市场的多年积累，销量一直居前。 市场规模突破千亿 随着人们健康意识的提升，益生菌产品受到青睐，市场规模也水涨船高，据中研普华产业研究院发布的《2024— 2029年益生菌行业市场深度调研与趋势预测研究报告》，2022年全球益生菌市场规模达到602.3亿美元，预计到 2030年将以8.7%的年均复合增长率增长，在2028年有望达到934.9亿美元。国内市场的增速尤为显著，2022年中国 益生菌市场规模已突破1000亿元大关，达到1065亿元，预计到2026年中国益生菌市场规模有望达到1377亿元。 尚普咨询集团调研显示，江中获2024年"中国益生菌冻干粉销量第一"。 益生菌产品的热卖，在电商平台有着更为明显的体现，30+年龄段家庭用户贡献主要增量。益生菌产品的热卖， 成为人们追求健康生活方式的一大 ...

智通财经APP获悉，东吴证券发布研报称，五个方向选股，优先确定性，自下而上于成长和困境反转中 捕捉估值切换收益，头部零食企业、优质连锁零售业态兼具"新且快"，迭代能力强，增速横向比较更领 先；低位布局积极出清的，2026年内出现拐点可能性大的白酒、乳业以及大餐饮板块，高度重视保健品 大健康领域，银发经济基本盘稳固，年轻化新消费人群扩容，品类创新迭代积极，主要公司弹性体现在 2026年。重视长生命周期与高壁垒生意龙头，以及深度价值（稳定格局，稳健经营，稳定分红）标的。 风险提示：宏观如继续承压对消费的传导，需求探底和修复不及预期，原材料价格的加大波动，食安风 险，行业内产能扩张和竞争加剧风险，估值切换收益提前兑现使得2026收益空间缩小的风险等。 以CPI指标为例，2020年9月份以来持续低位运行，其中2021年以来食品、烟、酒整体长期处于换档降 速通道，2023年中以来食品和酒类价格指数更是呈现连续负增长状态。宏观消费指标社会消费品零售总 额显示，2021年8月以来月度同比增长居于2%-5%的低速区间。结合餐饮和食品及酒类代表性上市公司 经营表现，消费持续承压已久。2024Q3以来"提振消费"被屡次提及，一方 ...

报道刊发后，香港大药房氨糖软骨素贴产品的生产企业南阳艾南山药业有限公司被河南省南阳市卧龙区/蒲山市场 监督管理所立案。12月8日，新京报记者回访发现，上述报道涉及的"香港大药房氨糖软骨素贴"产品原链接已下 架。不过，在同一家店铺friggbeauty旗舰店内，另有一款"Friggbeauty氨糖软骨素贴"产品上架，该产品宣传页面的 图文内容仍在暗示治疗功效。 记者看到，该店铺目前在售的"Friggbeauty氨糖软骨素贴"产品商标贴牌混乱：产品的首页宣传图显示 为"Friggbeauty氨糖软骨素贴"，首页介绍视频中产品图片却显示为"愈健宁氨糖软骨素贴"，评论区消费者发布的 图片则显示产品为"国医世堂氨糖软骨素贴"。 当记者就商标混乱的问题向店铺客服咨询，客服仅表示其是老品牌，销量名列前茅。随后，记者追问该链接究竟 是哪款产品，客服发来的图片，依旧是此前被点名的"香港大药房氨糖软骨素贴"。 在老龄化加速与全民健身风尚的背景下，骨关节健康成为公众关注焦点，氨糖市场也迎来消费热潮。其中，一些 喷雾、外敷类的外用氨糖产品凭借"便捷使用""直达病灶"等宣传，吸引了上班族、运动爱好者及中老年群体的关 注。今年10月，新 ...

Core Viewpoint - The company reported that its online sales channels are significantly diversified, with Douyin accounting for approximately 20% and Tmall and JD.com together making up about 60% of total online sales [1] Group 1: Revenue Breakdown - The main brand contributes over 50% to the company's total revenue [1] - The revenue from Jianlidu and Lifespace each exceeds 10% [1]

证券日报网12月9日讯汤臣倍健（300146）在12月9日回答调研者提问时表示，公司SKU较多，各产品间 复购率存在差异。今年主品牌线上推出的几大新品在拉动高消费人群增量方面表现较为亮眼。 ...

证券日报网12月9日讯汤臣倍健（300146）在12月9日回答调研者提问时表示，公司经销商数量近年来减 少的原因：主要是因为业务调整、经销商整合优化所致。鉴于公司持续探索新渠道、新品牌和新平台， 未来经销商的持续优化还是会存在。 ...